Highlights and Quick Summary
- Share Based Compensation of Revenue for the quarter ending February 28, 2023 was 3.39% (a -20.79% decrease compared to previous quarter)
- Year-over-year quarterly Share Based Compensation of Revenue increased by 69.5%
- Annual Share Based Compensation of Revenue for 2022 was 3.52% (a -28.46% decrease from previous year)
- Annual Share Based Compensation of Revenue for 2021 was 4.92% (a -45.21% decrease from previous year)
- Annual Share Based Compensation of Revenue for 2020 was 8.98% (a -51.51% decrease from previous year)
- Twelve month Share Based Compensation of Revenue ending February 28, 2023 was 4.08% (a 2.77% increase compared to previous quarter)
- Twelve month trailing Share Based Compensation of Revenue increased by 49.45% year-over-year
Trailing Share Based Compensation of Revenue for the last four month:
| 28 Feb '23 | 30 Nov '22 | 31 Aug '22 | 31 May '22 |
|---|---|---|---|
| 4.08% | 3.97% | 3.52% | 2.73% |
Visit stockrow.com/OGI
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Share Based Compensation of Revenue of Organigram Holdings Inc.
Most recent Share Based Compensation of Revenueof OGI including historical data for past 10 years.Interactive Chart of Share Based Compensation of Revenue of Organigram Holdings Inc.
Organigram Holdings Inc. Share Based Compensation of Revenue for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | 3.39% | – | – | – | – |
| 2022 | 4.28% | 6.23% | 2.0% | 2.73% | 3.52% |
| 2021 | 2.24% | 4.4% | 4.93% | 8.1% | 4.92% |
| 2020 | 3.14% | 4.59% | 8.99% | 10.38% | 8.98% |
| 2019 | 11.15% | 25.14% | 15.49% | 18.94% | 18.52% |
| 2018 | – | – | 14.85% | 0.0% | 40.49% |
| 2017 | – | – | – | – | 0.0% |
| 2016 | – | – | – | – | 0.0% |
Business Profile of Organigram Holdings Inc.
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic